Compound of angiotensin receptor blocker and levosimendan and use of compound
A technology of receptor antagonists and angiotensin, which is applied in the fields of cardiovascular system diseases, active ingredients of heterocyclic compounds, medical preparations containing active ingredients, etc., can solve the problem that the crystal structure of the compound is not determined and the property of the compound is unstable , No antihypertensive and other problems, to achieve the effect of providing pharmacokinetic properties, stable properties, and improving stability
Active Publication Date: 2016-12-14
赛隆药业集团股份有限公司(长沙)医药研发中心
View PDF4 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0011] However, there are currently no clinically effective drugs for the treatment of heart failure and hypertension, and most drugs have unavoidable side effects while relieving symptoms of heart failure and hypertension
And the order of a single drug is prone to tolerance. In order to treat heart failure and hypertension more effectively, some compounds have been developed in the prior art, such as the drug compound containing valsarta...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0034] Example 1 A complex of angiotensin receptor antagonist and levosimendan
[0035] The complex includes 1 mol of valsartan and 1 mol of levosimendan.
Embodiment 2
[0036] Example 2 A complex of angiotensin receptor antagonist and levosimendan
[0037] The complex includes 1 mol of Olmesartan and 1 mol of Levosimendan.
Embodiment 3
[0038] Example 3 A complex of angiotensin receptor antagonist and levosimendan
[0039] The complex includes 1 mol of Telmisartan and 2 mol of Levosimendan.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more
Abstract
The invention provides a compound of an angiotensin receptor blocker and levosimendan and use of the compound. The compound is composed of the angiotensin receptor blocker and levosimendan, which can be mixed directly or be connected indirectly through a hydrogen bond, wherein a co-crystallized sodium hydrate formed by connection through hydrogen bond is more stable in property; and the pharmacokinetic properties are improved significantly; the action mechanisms of the angiotensin receptor blocker and the levosimendan are different, but the formed compound has an unexpected synergistic effect and has positive application prospects in the anti-heart failure and anti-hypertensive treatment field.
Description
Technical field [0001] The invention belongs to the field of medicines for treating cardiovascular diseases, and particularly relates to a complex of an angiotensin receptor antagonist and levosimendan and its use. Background technique [0002] Heart failure (abbreviated as heart failure) is a complex group of clinical symptoms, which is a severe stage of various heart diseases, with a high incidence rate and a 5-year survival rate similar to that of malignant tumors. The incidence of heart failure in the near future will continue to increase, and it is becoming the most important cardiovascular disease in the 21st century. [0003] According to foreign statistics, the prevalence of central failure in the population is about 1.5% to 2.0%, and it can reach 6% to 10% for people over 65. In the past 40 years, deaths caused by heart failure have increased by 6 times. Heart failure is due to any initial myocardial damage (such as myocardial infarction, cardiomyopathy, hemodynamic overl...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
IPC IPC(8): A61K31/50A61K31/41A61K31/4178A61K31/4184A61K31/519A61P9/00A61P9/12A61P3/06
CPCA61K31/41A61K31/4178A61K31/4184A61K31/50A61K31/519A61K2300/00
Inventor 李剑峰周文吴彪
Owner 赛隆药业集团股份有限公司(长沙)医药研发中心
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap